CJC1295 With DAC 2mg/vial CAS:446262-90-4

   What is CJC-1295 with DAC?

    ●Core Identity: CJC-1295 is a synthetic analog of Growth Hormone-Releasing Hormone (GHRH). GHRH is a natural hypothalamic hormone that signals the pituitary gland to synthesize and release pulses of GH.

    ●The DAC Modification: This is the critical differentiator. DAC is a chemical moiety (lysine linker and maleimidopropionyl group) covalently attached to the CJC-1295 peptide. Its primary function is irreversible binding to circulating albumin, the most abundant protein in blood plasma.

    ●Mechanism of Action: Once injected, the DAC component rapidly binds CJC-1295 to albumin. This albumin-peptide complex acts as a reservoir, protecting CJC-1295 from rapid enzymatic degradation (like dipeptidyl peptidase-4 - DPP-4) and renal clearance. Bound CJC-1295 continuously dissociates slowly from albumin over days, providing a sustained, low-level stimulation of the pituitary's GHRH receptors. This leads to an elevation of baseline GH levels and a significant increase in both the frequency and amplitude of natural GH pulses, resulting in substantially elevated and prolonged IGF-1 levels.

    ●Extended Half-Life: This is the defining feature. While native GHRH lasts minutes and CJC-1295 without DAC lasts roughly 30 minutes, CJC-1295 with DAC boasts a terminal half-life of approximately 6-8 days in humans. This is a revolutionary extension.

    ●Albumin Binding: The irreversible binding to albumin is the direct cause of the prolonged half-life and sustained activity.

    ●Pulsatile Secretion Preservation: Unlike exogenous GH injections (which suppress natural pulsatility) or continuous GHRH infusions (which can desensitize receptors), the sustained release from the albumin reservoir mimics the body's natural episodic pattern of GH release more closely. This is theorized to maintain pituitary sensitivity better over time.

    ●Stability: The DAC modification significantly enhances resistance to proteolytic enzymes in the bloodstream.

    ●Dosage Form: The 2mg vial is a common presentation for research and clinical trial purposes, requiring reconstitution with bacteriostatic water before subcutaneous (SC) or intramuscular (IM) injection. The actual usable peptide quantity is 2mg per vial.

    ●Endogenous Pathway Activation: It works by amplifying the body's own GH production machinery, leading to increases in both GH and IGF-1, rather than introducing synthetic GH.

    CJC-1295 with DAC is utilized by bodybuilders and athletes primarily to leverage the anabolic and metabolic effects of elevated GH and IGF-1 levels:

    ●Muscle Hypertrophy (Growth): Increased IGF-1 directly stimulates muscle protein synthesis (MPS), satellite cell activation, and muscle cell proliferation/differentiation, promoting significant lean muscle mass gains.

    ●Enhanced Fat Loss (Lipolysis): GH is a potent lipolytic hormone, promoting the breakdown of stored triglycerides in adipose tissue (fat) into free fatty acids for energy. This leads to reduced body fat percentage and improved muscle definition.

    ●Accelerated Recovery: GH and IGF-1 play crucial roles in tissue repair and regeneration. Users report faster recovery between workouts, reduced muscle soreness (DOMS), and potentially quicker healing from minor injuries.

    ●Improved Sleep Quality: Some users report deeper sleep, which is beneficial for overall recovery and GH secretion (as natural GH pulses peak during deep sleep).

    ●Joint and Connective Tissue Support: GH and IGF-1 stimulate collagen synthesis, potentially improving joint health, reducing discomfort, and strengthening tendons and ligaments – important for heavy lifters.

    ●Off-Season Bulking & Contest Preparation: Used during bulking phases to maximize lean mass accrual and during cutting phases to preserve muscle mass while aggressively burning fat.

    ●Sustained Anabolic Environment: Provides continuous stimulation for muscle growth and repair over days, not hours.

    ●Significant IGF-1 Elevation: Clinical studies show increases in serum IGF-1 levels by 2-3 times baseline, sustained for over a week after a single dose. This is a key driver for muscle growth.

    ●Potent Fat Loss: Enhanced lipolysis contributes to a leaner, harder physique.

    ●Reduced Injection Frequency: The primary practical benefit. Dosing is typically only 1-2 times per week compared to daily or multiple times daily injections required for GHRPs (like Ipamorelin) or CJC-1295 without DAC.

    ●Preserved Natural Pulsatility: Theoretically lowers the risk of pituitary desensitization compared to constant GHRH infusion, though long-term high-dose data in bodybuilding contexts is lacking.

    ●Synergy: Often stacked effectively with GHRPs (Ipamorelin, GHRP-2, GHRP-6) to amplify GH pulse amplitude and potentially provide more "bursts" of GH release on top of the elevated baseline. Also commonly stacked with insulin-sensitizing compounds during bulking (e.g., Metformin, Berberine).

    ●Dosage Range (Bodybuilding Context): Typical doses range from 1mg to 2mg per week. Common protocols involve:

    ○1mg twice per week (e.g., Monday & Thursday)

    ○2mg once per week.

    ○Starting at the lower end (1mg/week) is advisable to assess tolerance.

    ●Administration: Reconstituted peptide is administered via subcutaneous (SC) injection into fatty tissue (abdomen, thigh, glute). Intramuscular (IM) is also possible but not necessary and may cause more localized discomfort. Sterile technique is paramount.

    ●Cycle Length: Common cycles range from 8 to 16 weeks. Due to the extremely long half-life and sustained IGF-1 elevation, longer cycles (e.g., 12-16 weeks) are frequently employed. However, the optimal duration isn't definitively established, and concerns about potential receptor desensitization or downregulation with prolonged, high-dose use suggest implementing breaks.

    ●Cycling Strategy:

    ○On-Cycle: 8-16 weeks at 1-2mg/week.

   ○ Off-Cycle: A break equal to or slightly longer than the cycle length is recommended (e.g., 8-16 weeks off). This allows GH/IGF-1 axis normalization and resets receptor sensitivity. There is no established PCT (Post Cycle Therapy) protocol specific to GH peptides like there is for steroids.

    ●Timing: Timing relative to workouts or meals is considered less critical than with short-acting peptides due to the sustained release. Some prefer dosing before bed to potentially synergize with the natural nocturnal GH surge, but any consistent weekly schedule is acceptable.

    ●Terminal Half-Life: ~6-8 days. This is the time it takes for the concentration of the active peptide-albumin complex to reduce by half in the bloodstream after the initial distribution phase.

    ●Peak Concentration (Tmax): Occurs relatively quickly after injection (within a few hours), but the effects (GH/IGF-1 elevation) peak later.

    ●Duration of Action: A single injection significantly elevates GH pulsatility and IGF-1 levels for over 7 days, with IGF-1 levels typically peaking around 2-3 days post-injection and remaining substantially elevated for 6-10+ days.

    ●Accumulation: Due to the long half-life, repeated weekly dosing leads to significant accumulation in the bloodstream. Steady-state levels are reached after approximately 4-5 half-lives (around 4-6 weeks). This means effects intensify over the first month of a cycle.

    ●PTC Nuance: Unlike anabolic steroids, which severely suppress the hypothalamic-pituitary-gonadal (HPG) axis, CJC-1295 with DAC works through the pituitary's natural GHRH receptors. There is no direct suppression of the HPT axis (testosterone production).

    ○Recovery: After discontinuation, GH and IGF-1 levels will gradually decline back to baseline over several weeks due to the long half-life and cessation of stimulation. There is no "crash," but the anabolic/fat-burning benefits cease.

    ○PTC Focus: The primary focus isn't on restarting testosterone production (like with SERMs for steroids), but rather on:

    ◇Allowing Receptor Reset: The extended off-period (8-16 weeks) is crucial to prevent potential downregulation of GHRH receptors in the pituitary, which could diminish effectiveness over time.

    ◇Metabolic Health: Supporting insulin sensitivity (diet, exercise, compounds like Berberine/Metformin if needed) is important, as prolonged high IGF-1 can impact glucose metabolism.

    ◇Overall Health Monitoring: Basic blood work (IGF-1, glucose, lipids, liver/kidney markers) before, during, and after cycles is prudent.

    ●Safety & Side Effects (Potential):

    ○Hyperglycemia/Insulin Resistance: Elevated GH/IGF-1 can antagonize insulin action, potentially leading to increased blood sugar levels.    Monitoring and managing carbohydrate intake/insulin sensitivity is vital.

    ○Water Retention: Common, especially initially, causing a "puffy" look and potential carpal tunnel syndrome-like symptoms (numbness/tingling in hands).

    ○Increased Appetite: Stimulation of GH pathways can increase hunger.

    ○Numbness/Tingling: Related to water retention impacting nerves.

    ○Headaches: Less common.

    ○Lethargy: Reported by some users.

    ○Injection Site Reactions: Redness, itching, or lumps.

    ○Acromegaly-like Symptoms: Theoretical risk only with extreme, prolonged misuse: Enlargement of hands, feet, facial bones, internal organs. Responsible dosing and cycling mitigate this.

    ○Carcinogenic Potential: GH/IGF-1 are potent growth factors. While no direct causal link is proven in humans using peptides at bodybuilding doses, individuals with active cancer or a strong history should absolutely avoid these compounds. The long-term cancer risk profile is unknown.

    ○Pituitary Health: Long-term, high-dose impact on pituitary function remains unclear. Breaks are essential.

Trade names	DAC,GRF
CAS	446262-90-4
Molar mass	3367.954
Formula	C152H252N44O42
Purity	Above 98%
Apprarance	2mg/vial,Lyophilized powder

 

 

Any needs, please contact us

Email: Jasonraws106@gmail.com

WhatsApp: +86-15572565525
Telegram: +86-15871669785

   

                                   

 

    CJC-1295 with DAC (2mg) offers a unique proposition for bodybuilders: significant, sustained elevation of GH and IGF-1 with minimal (1-2x weekly) injections. Its mechanism – leveraging albumin binding for prolonged activity while preserving natural pulsatility – sets it apart. The benefits of potent muscle growth, fat loss, and enhanced recovery are compelling.

    However, critical realities must be acknowledged:

    1.Research Chemical Status: It is primarily sold as a research chemical, not an FDA-approved pharmaceutical for bodybuilding or anti-aging. Quality control, purity, and sterility are major concerns in the gray market.

    2.Individual Variability: Responses vary greatly based on genetics, age, diet, training, overall health, and potentially product quality.

    3.Long-Term Safety Unknown: The safety profile of repeated, high-dose cycles over years in healthy individuals is not established. Potential impacts on glucose metabolism, cardiovascular health, and cancer risk require caution and monitoring.

    4.Cost vs. Benefit: High-quality peptides are expensive, and results, while significant for some, are generally subtler than potent anabolic steroids.

    5.Regulatory & Ethical Status: Use in competitive sports is banned by WADA and most athletic organizations.

    CJC-1295 with DAC is a powerful tool within the modern bodybuilder's arsenal, offering a practical and effective means to elevate anabolic hormones endogenously. Its long half-life is its greatest strength, enabling sustained effects with infrequent dosing. However, it demands a responsible approach: thorough research, sourcing concerns, vigilant health monitoring, responsible dosing/cycling, and a clear understanding of the potential risks and regulatory implications. It is not a magic solution, but rather a sophisticated compound that works best as part of a meticulously planned regimen built on foundational pillars of intense training, precise nutrition, and adequate recovery. Consulting a healthcare professional knowledgeable about peptide therapy is strongly advised before use.

Hot Tags: cjc1295 with dac 2mg/vial cas:446262-90-4, China cjc1295 with dac 2mg/vial cas:446262-90-4 manufacturers, suppliers, factory